BANK OF AMERICA CORP /DE/
BankPosition in XERS — Xeris Biopharma Holdings, Inc.
CIK 70858
CHARLOTTE, NC
Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,064,635
+$5,993,133 QoQ
Shares Held
1,397,050
+59.8% QoQ
Ownership
0.766%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $1,596,028,663 across 49 Drug Manufacturers - Specialty & Generic names. XERS ranks #22 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,926 | $282,045,178 | |
| 2 | LQDA |
Liquidia Corp
|
1,991,566 | $158,787,554 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,227,607 | $143,231,322 | |
| 4 | VTRS |
Viatris Inc
|
7,356,708 | $116,824,520 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
619,352 | $104,385,582 | |
| 6 | HLN |
Haleon plc
|
10,850,097 | $101,231,403 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
179,235 | $97,114,896 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,909,871 | $96,221,922 |
All Filings in XERS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,064,635 | 1,397,050 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,071,502 | 874,397 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $5,635,624 | 717,914 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $12,982,207 | 1,594,866 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $7,768,497 | 1,663,490 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,384,654 | 1,709,409 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,361,715 | 991,657 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,876,222 | 1,009,201 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,443,748 | 641,666 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,387,982 | 628,047 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $611,890 | 260,379 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $129,803 | 69,787 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $32,406 | 12,369 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $77,565 | 47,586 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $125,015 | 93,997 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $118,463 | 75,939 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $171,663 | 111,471 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $119,910 | 46,841 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $87,042 | 29,708 | Shares | Defined | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||